XANA™ is medical technology company which creates smart & non-invasive  stimulators to modulate the activity of the brain.

Anormal neuronal electrical signals are present in a wide range of disorders including anxiety and mood disorders, chronic pain, cardiological diseases, memory impairment and aging-related neurodegeneration, hearing loss, and/or tinnitus, among many others.

The current pharmacological treatment doesn’t work as well and is safe as desired. On the other hand, existing medical devices to stimulate the brain are emerging as tremendously powerful therapeutic tools that could revolutionize the treatment of brain diseases. 


Unfortunately, existing devices to modulate brain activity by stimulation have serious handicaps. Invasiveness, low usability because of limited miniaturization, and the lack of personalization of the treatments hamper the adequate clinical effect and render these solutions unattractive for clinicians and patients.

XANA™ has demonstrated the capacity to change the today’s state-of-the-art microelectronics and microfabrication to create wireless neuro-devices with high levels of miniaturization, multi-site sensor/stimulator arrays and low power consumption, leading to lower risk, shorter recovery times, and better patient acceptance.


XANA™ takes advantage of all the potential of the digital technologies to personalize the treatments as well as provide objective data about the effecicacy of the therapy. 

The monitoring of both of the doses delivered as well as the real-time effect on the body allows the creation of unique neuromodulation systems.

We have created and validated our own algorithm to measure the impact of the stimulation in several physiological indicators.

Thus, we have created a unique closed-loop system to personalize the treatments and allow both clinicians and patients to test the efficacy of the treatment in the short and lont-term.

Supported by